Education
About Us
Working with TipRanks
Follow Us
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 47.98M | $ 96.73M | $ 48.58M | $ 18.26M | $ 9.33M |
| Gross Profit | $ 47.98M | $ 96.37M | $ 47.03M | $ 17.14M | $ -57.67M |
| Operating Income | $ -73.36M | $ 21.48M | $ -42.20M | $ -87.97M | $ -79.11M |
| EBITDA | $ -73.36M | $ 25.77M | $ -42.26M | $ -87.17M | $ -76.93M |
| Net Income | $ -68.57M | $ 22.81M | $ -48.03M | $ -91.30M | $ -77.52M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 52.89M | $ 76.33M | $ 109.11M | $ 146.40M | $ 126.91M |
| Total Assets | $ 110.54M | $ 182.39M | $ 124.80M | $ 171.07M | $ 153.45M |
| Total Debt | $ 4.30M | $ 5.54M | $ 6.65M | $ 7.33M | $ 7.84M |
| Net Debt | $ -48.59M | $ -70.79M | $ -102.46M | $ -105.25M | $ -77.37M |
| Total Liabilities | $ 64.42M | $ 75.50M | $ 48.87M | $ 82.78M | $ 21.41M |
| Stockholders' Equity | $ 46.12M | $ 106.89M | $ 75.93M | $ 88.29M | $ 132.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -23.44M | $ -32.99M | $ -7.73M | $ -64.31M | $ -86.03M |
| Operating Cash Flow | $ -23.44M | $ -32.99M | $ -7.73M | $ -64.35M | $ -85.87M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 33.81M | $ 7.67M | $ 10.47M |
| Financing Cash Flow | $ 0.00 | $ 221.00K | $ -29.55M | $ 84.05M | $ 130.88M |